## Role DisclosureEquityIncentivePlansTables

**Year Ended**

|  | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| --- | --- | --- | --- |
| **  Summary of Stock Option and RSU Activity** | The following table summarizes our stock option and RSU activity for the year 
ended December 31, 2021:

                                                               Weighted-        
Weighted-              
                                                Weighted-      Average          
Average                
                                                Average        Remaining        
Grant                  
                                                Exercise       Contractual      
Date Fair              
                                                Price          Life (years)     
Value                  
  Beginning of period              146,933      $68.26                          
18,789      $              136.49  
  Granted                              925      $830.83                         
2,192      $              784.00  
  Exercised or released           ( 27,359      $16.82                          
( 7,877      $              115.36  
  Cancelled                        ( 1,459      $195.10                         
( 1,667      $              208.37  
  End of period                    119,040      $84.46         5.98             
11,437      $              264.68  
  Vested and expected              115,794      $83.15                          
11,181      $              250.49  
  Exercisable and vested,           67,828      $74.47                          

(1)

Tranche 8 of the 2018 CEO Performance Award, which represents

8.4

million stock options, was achieved in the fourth quarter of 2021 and will vest 
upon expected certification following the filing of this Annual Report on Form 
10-K.
 |  |  |
| **  Schedule of Fair Value of Stock Option Award and ESPP on Grant Date** | The weighted-average assumptions used in the Black-Scholes model for stock 
options are as follows:

                                       Year Ended December 31,                  
                                       2021                                     
2020                  2019             
 ───────────────────────────────────────────────────────────────────────────────
────────────────────────────────────────
  Risk-free interest rate                                             0.66      
0.26                  2.4  
  Expected term (in years)                                             4.3      
3.9                  4.5  
  Expected volatility                                                   59      
69                   48  
  Dividend yield                                                       0.0      
0.0                  0.0  
  Grant date fair value per share      $                            384.07      
$         216.14      $         22.32
 |  |  |
| **  Summary of Operational Milestone Based on Revenue or Adjusted EBITDA** | The achievement status of the operational milestones as of December 31, 2021 is 
provided below. Although an operational milestone is deemed achieved in the last
quarter of the relevant annualized period, it may be certified only after the 
financial statements supporting its achievement have been filed with our Forms 
10-Q and/or 10-K.

  Total Annualized Revenue                              Annualized Adjusted 
EBITDA                          
                 Milestone      Achievement Status                       
Milestone      Achievement Status  
                     $20.0      Achieved                                      
$1.5      Achieved            
                     $35.0      Achieved                                      
$3.0      Achieved            
                     $55.0      Probable                                      
$4.5      Achieved            
                     $75.0      Probable                                      
$6.0      Achieved            
                    $100.0      -                                             
$8.0      Achieved            
                    $125.0      -                                            
$10.0      Achieved (1)        
                    $150.0      -                                            
$12.0      Probable            
                    $175.0      -                                            
$14.0      Probable            

(1)

Achieved in the fourth quarter of 2021 and expected to be certified following 
the filing of this Annual Report on Form 10-K.
 |  |  |
| **  Summary of Stock-Based Compensation Expense** | The following table summarizes our stock-based compensation expense by line item
in the consolidated statements of operations (in millions):

                                           Year Ended December 31,              
                                           2021                                 
2020                 2019           
 ───────────────────────────────────────────────────────────────────────────────
────────────────────────────────────────
  Cost of revenues                         $                              421   
$           281      $         128  
  Research and development                                                448   
346                285  
  Selling, general and administrative                                   1,252   
1,107                482  
  Restructuring and other                                                   —   
—                  3  
  Total                                    $                            2,121   
$         1,734      $         898
 |  |  |